These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 6361995)

  • 1. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
    Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
    Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tolerability profile of prophylactic norfloxacin in neutropenic patients.
    Corrado ML; Struble WE; Hesney M
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S29-33. PubMed ID: 3280325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
    Henry SA
    Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
    Cortelezzi A; Radaelli F; Penagini R; Pogliani EM
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):520-3. PubMed ID: 6983502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
    Wolff LJ
    Am J Pediatr Hematol Oncol; 1984; 6(3):267-76. PubMed ID: 6393790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.
    Wade JC; Schimpff SC; Hargadon MT; Fortner CL; Young VM; Wiernik PH
    N Engl J Med; 1981 Apr; 304(18):1057-62. PubMed ID: 6782486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing infection in neutropenic cancer patients.
    Beutler SM; Barth NM; Bayer AS
    West J Med; 1983 May; 138(5):690-8. PubMed ID: 6880186
    [No Abstract]   [Full Text] [Related]  

  • 13. Low morbidity and mortality from infection in neutropenic patients, a possible result of multiple measures of infection prevention.
    Grob JP; Francioli P; Pécoud A; Glauser MP
    Schweiz Med Wochenschr Suppl; 1983; 14():70-5. PubMed ID: 6581532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative randomized study of protected environment plus oral antibiotics versus oral antibiotics alone in neutropenic patients.
    Lohner D; Debusscher L; Prévost JM; Klastersky J
    Cancer Treat Rep; 1979 Mar; 63(3):363-8. PubMed ID: 106963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intestinal decontamination in the neutropenic patient. Apropos of a prospective randomized study].
    Pellegrin JL; Fourche J; Marit G; David B; Texier J; Reiffers J; Leng B; Broustet A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):676-9. PubMed ID: 3095780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].
    Scaglione C; Tormena AM; Pavlovsky S
    Sangre (Barc); 1982; 27(5):912-8. PubMed ID: 6820192
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections caused by viridans streptococci in patients with neutropenia.
    Tunkel AR; Sepkowitz KA
    Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
    J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients.
    Guiot HF; van Furth R
    Infection; 1984; 12(1):1-4. PubMed ID: 6423548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.